Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sakae Tanaka

Showing results (31-40 of 913) with videos related to

Pageof 92
Sort By:
Advances in Experimental Medicine and Biology|October 31, 2007
Ectodomain shedding of receptor activator of NF-kappaB ligandAtsuhiko Hikita, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 5, 2015
[Anti-RANKL antibody]Toshinobu Omiya, Sakae Tanaka
Clinical Calcium|May 3, 2012
[Epigenetic regulation of osteoclastogenesis by histone modification]Yasunori Omata, Sakae Tanaka
Clinical Calcium|June 2, 2012
[Etiology of osteoporosis -decrease of bone mineral density and deterioration of bone quality-]Satoru Ohashi, Sakae Tanaka
Clinical Calcium|December 27, 2013
[Updates of denosumab, anti-RANKL antibody for osteoporosis]Naoto Tokuyama, Sakae Tanaka
Clinical Calcium|July 27, 2017
[New methods for the evaluation of bone quality. Bone quality evaluation by QCT.]Satoru Ohashi, Sakae Tanaka
Clinical Calcium|April 28, 2016
[Mechanism of bone destruction in rheumatoid arthritis and perspectives of the treatment]Takuma Koyama, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 24, 2004
[Novel therapeutic approach to bone metabolic disorders using RANKL vaccination]Takuo Juji, Sakae Tanaka
Arthritis Research & Therapy|May 17, 2017
Molecular mechanisms underlying osteoarthritis development: Notch and NF-κBTaku Saito, Sakae Tanaka
The Journal of Clinical Investigation|September 23, 2009
NF-kappaB2 (p100) limits TNF-alpha-induced osteoclastogenesisSakae Tanaka, Hiroyasu Nakano
Pageof 92

Showing results (31-40 of 913) with videos related to

Sort By:
Pageof 92
Advances in Experimental Medicine and Biology|October 31, 2007
Ectodomain shedding of receptor activator of NF-kappaB ligandAtsuhiko Hikita, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 5, 2015
[Anti-RANKL antibody]Toshinobu Omiya, Sakae Tanaka
Clinical Calcium|May 3, 2012
[Epigenetic regulation of osteoclastogenesis by histone modification]Yasunori Omata, Sakae Tanaka
Clinical Calcium|June 2, 2012
[Etiology of osteoporosis -decrease of bone mineral density and deterioration of bone quality-]Satoru Ohashi, Sakae Tanaka
Clinical Calcium|December 27, 2013
[Updates of denosumab, anti-RANKL antibody for osteoporosis]Naoto Tokuyama, Sakae Tanaka
Clinical Calcium|July 27, 2017
[New methods for the evaluation of bone quality. Bone quality evaluation by QCT.]Satoru Ohashi, Sakae Tanaka
Clinical Calcium|April 28, 2016
[Mechanism of bone destruction in rheumatoid arthritis and perspectives of the treatment]Takuma Koyama, Sakae Tanaka
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 24, 2004
[Novel therapeutic approach to bone metabolic disorders using RANKL vaccination]Takuo Juji, Sakae Tanaka
Arthritis Research & Therapy|May 17, 2017
Molecular mechanisms underlying osteoarthritis development: Notch and NF-κBTaku Saito, Sakae Tanaka
The Journal of Clinical Investigation|September 23, 2009
NF-kappaB2 (p100) limits TNF-alpha-induced osteoclastogenesisSakae Tanaka, Hiroyasu Nakano
Pageof 92